SyntheticMR Overview
- Year Founded
-
2007
- Status
-
Public
- Employees
-
40
- Stock Symbol
-
SYNT
- Investments
-
1
- Share Price
-
$0.42
- (As of Thursday Closing)
SyntheticMR General Information
Description
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.
Contact Information
Website
www.syntheticmr.comCorporate Office
- Storgatan 11
- 582 23 Linkoping
- Sweden
Corporate Office
- Storgatan 11
- 582 23 Linkoping
- Sweden
SyntheticMR Stock Performance
As of 27-Mar-2025, SyntheticMR’s stock price is $0.42. Its current market cap is $24.8M with 59.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.42 | $0.42 | $0.34 - $2.73 | $24.8M | 59.6M | 124K | -$0.04 |
SyntheticMR Financials Summary
As of 31-Dec-2024, SyntheticMR has a trailing 12-month revenue of $5.26M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 15,657 | 15,657 | 108,317 | 131,006 |
| Revenue | 5,264 | 5,264 | 8,393 | 6,730 |
| EBITDA | (1,077) | (1,077) | 1,912 | 1,295 |
| Net Income | (1,521) | (1,521) | 942 | 580 |
| Total Assets | 15,638 | 15,638 | 14,305 | 12,216 |
| Total Debt | 0 | 0 | 126 | 218 |
SyntheticMR Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SyntheticMR Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SyntheticMR Patents
SyntheticMR Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150177350-A1 | Methods and systems for improved magnetic resonance acquisition | Active | 02-Jul-2012 | ||
| US-10073156-B2 | Methods and systems for improved magnetic resonance acquisition | Active | 02-Jul-2012 | ||
| EP-2867689-B1 | Methods and systems for improved magnetic resonance acquistion | Active | 02-Jul-2012 | ||
| EP-2867689-A1 | Methods and systems for improved magnetic resonance acquistion | Active | 02-Jul-2012 | ||
| EP-2867689-A4 | Methods and systems for improved magnetic resonance acquistion | Active | 02-Jul-2012 | G01R33/50 |
SyntheticMR Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SyntheticMR Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
SyntheticMR Acquisitions (1)
SyntheticMR’s most recent deal was a Merger/Acquisition with Combinostics for . The deal was made on 02-Jan-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Combinostics | 02-Jan-2025 | Merger/Acquisition | Decision/Risk Analysis |
SyntheticMR ESG
Risk Overview
Risk Rating
Updated November, 10, 2022
30.26 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,048
Rank
Percentile
Healthcare
Industry
of 635
Rank
Percentile
Medical Devices
Subindustry
of 225
Rank
Percentile
SyntheticMR Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Combinostics | Tampere, Finland | 2014 |
SyntheticMR FAQs
-
When was SyntheticMR founded?
SyntheticMR was founded in 2007.
-
Where is SyntheticMR headquartered?
SyntheticMR is headquartered in Linkoping, Sweden.
-
What is the size of SyntheticMR?
SyntheticMR has 40 total employees.
-
What industry is SyntheticMR in?
SyntheticMR’s primary industry is Decision/Risk Analysis.
-
Is SyntheticMR a private or public company?
SyntheticMR is a Public company.
-
What is SyntheticMR’s stock symbol?
The ticker symbol for SyntheticMR is SYNT.
-
What is the current stock price of SyntheticMR?
As of 27-Mar-2025 the stock price of SyntheticMR is $0.42.
-
What is the current market cap of SyntheticMR?
The current market capitalization of SyntheticMR is $24.8M.
-
What is SyntheticMR’s current revenue?
The trailing twelve month revenue for SyntheticMR is $5.26M.
-
What is SyntheticMR’s annual earnings per share (EPS)?
SyntheticMR’s EPS for 12 months was -$0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
